Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL).
Jae-Cheol JoJin Seok KimJe Hwan LeeJung-Hee LeeSung-Nam LimSang Min LeeSung-Soo YoonIn-Ho KimSung Hwa BaeYoo Jin LeeYunsuk ChoiWon-Sik LeePublished in: Bone marrow transplantation (2020)